EXERCISE OPTION PERIOD 1

锻炼选项第 1 期

• 批准号: 10719183
• 负责人: SYLVIA ERNST
• 金额: $ 58.68万
• 依托单位: COLLABORATIVE DRUG DISCOVERY, INC.
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-06-01 至 2023-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10719183
• 关键词: Biological Assay; Chemical Structure; Chemicals; Computer software; Contractor; Data; Databases; Exercise; Funding; Information Systems; Information Technology; Online Systems; Pharmacology and Toxicology; United States National Institutes of Health; analog; member; user-friendly

The Contractor shall provide a centralized, web-based, information technology (IT) database that will provide user-friendly interfaces for entering, uploading/importing, searching, downloading/exporting, and visualizing chemical structures and bioactivity, pharmacology, and toxicology data, as well as software technical support. The centralized data system will collect and maintain data which includes, but is not limited to, information on the chemical analogs produced by NIH-funded contractors and PIs (including chemical structures) and data from bioactivity, pharmacology, and toxicology assays. The data will be reviewed and analyzed by members of an LDT, PIs, CROs, NIH-hired consultants, and NIH staff.

承包商应提供一个集中的、基于网络的信息技术(IT)数据库，该数据库将提供用户友好的界面，用于输入、上传/导入、 搜索、下载/导出和可视化化学结构和生物活性、药理学和毒理学数据，以及软件技术支持。中央数据系统将收集和维护数据，包括但不限于，由NIH资助的承包商和PI(包括化学结构)生产的化学类似物的信息，以及来自生物活性、药理学和毒理学分析的数据。数据将由LDT成员、PI、CRO、NIH聘请的顾问和NIH工作人员审查和分析。